Research analysts at William Blair lowered their Q2 2026 earnings estimates for J.Jill in a report released on Thursday, ...

Investment analysts at William Blair increased their Q2 2025 EPS estimates for shares of Incyte in a research note issued on Tuesday, March 18th. William Blair analyst M. Phipps now expects that the ...

Welcome to the Amprius Technologies fourth quarter and full-year 2024 earnings conference call. Joining us for today's presentation are the company's CEO, Dr. Kang Sun; and CFO, Sandra Wallach.

In a report released today, Jed Dorsheimer from William Blair maintained a Hold rating on Amprius Technologies Inc (AMPX – Research Report).

Discover how Torrid Holdings Inc. achieved strong Q4 2024 results through new sub-brands, strategic innovations, and financial discipline.

In a report released today, Matt Larew from William Blair maintained a Hold rating on Maravai Lifesciences Holdings (MRVI – Research Report).

A hit to earnings from high inflation and interest rates have chipped 13% off Indian stocks from September's record high, wiping out $1 trillion in market value ...

Balaji Gandhi; Chief Financial Officer; Phreesia Inc. Chaim Indig; Chief Executive Officer, Director; Phreesia Inc. Anne McCormick; Analyst; JPMorgan Chase & Co. Jes ...

Stephen Silvestro; President, Chief Executive Officer; OPTIMIZERx Corp. Edward Stelmakh; Chief Financial Officer, Chief Operating Officer; OPTIMIZERx Corp. Andrew D' ...

Scott Salmirs; President, Chief Executive Officer, Director; ABM Industries Inc Earl Ellis; Chief Financial Officer, Executive Vice President; ABM Industries Inc Timothy Mulrooney; Analyst; William ...

CFO Asaf Berenstin provided details of the merger, stating that Magic shareholders will own 31.125% of the merged entity. The combined market capitalization is estimated at $2.3 billion, with ...

Primo Brands Corporation ("Primo Brands" or the "Company") today announced that one of its stockholders (the "Selling Stockholder"), an affiliate of One Rock Capital Partners, intends to offer for ...